Watch this case-based CME-approved recording with Jamie E. Chaft, MD, as she discusses molecular and clinical factors that can inform first- and second-line treatment strategies for patients with NSCLC.

In this multidisciplinary discussion, James B. Bussel, MD & Allison Miller Imahiyerobo, APN explore ITP pathogenesis, current and emerging therapies, and supportive care strategies that help ITP patients achieve their goals of therapy. Register/sign in to get started!

In this online activity, Srdan Verstovsek, MD, PhD, explores predictive and prognostic markers for personalized care planning in myelofibrosis as well as emerging data in therapeutic strategies and the implications that research advances may have for future practice.